Quetiapine in the Management of Psychosis Secondary to Huntington's Disease: A Case Report

Leroi I Michalon M. Treatment of the psychiatric manifestations of Huntington's disease: A review of the literature. Can J Psychiatry 1998;43:933–40.

Naarding P Kremer HPH Zitman FG . Huntington's disease: A review of the literature on prevalence and treatment of neuropsychiatric phenomena. Eur Psychiatry 2001;16:439–45.

Shiwach R. Psychopathology in Huntington's disease patients. Acta Psychiatr Scand 1994;90:241–6.

Sajatovic M Verbanac P Ramirez LF Meltzer HY . Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea. Neurology 1991;41:156.

Madhusoodanan S Brenner R. Use of risperidone in psychosis associated with Huntington's disease. Am J Ger Psychiatry 1998;6:347–9.

Paleacu D Anca M Giladi N. Olanzapine in Huntington's disease. Acta Neurol Scand 2002;105:441–4.

Bonelli RM Mahnert FA Niederweiser G. Olanzapine for Huntington's disease: An open label study. Clin Neuropharmacol 2002;25:263–5.

Bonelli RM Niederwieser G. Quetiapine in Huntington's disease: A first case report. J Neurol 2002;249:1114–5.

Chouinard G Ross-Chouinard A Annable L Jones BD . Extrapyramidal rating scale. Can J Neurol Sci 1980;7:233.